Luke F. Moat

This paper develops AMLS, an evolutionary learning method combined with SVR, to identify a miRNA signature for improved survival prediction in AML, achieving high prognostic accuracy.

This study identifies a novel tumor-predisposing syndrome linked to long telomeres through common and rare genetic variants.

This study shows NR2E3 activates p53 and induces apoptosis in cancer cells, with its agonist 11a synergizing with Romidepsin to suppress cervical cancer through multiple molecular mechanisms.